Skip to main content
Figure 2 | BMC Clinical Pharmacology

Figure 2

From: Renal safety of zoledronic acid with thalidomide in patients with myeloma: a pharmacokinetic and safety sub-study

Figure 2

Means (± standard deviations) of serum creatinines prior to (up to 16) infusions of zoledronic acid in patients on Arm1 (diamonds) [receiving zoledronic acid, thalidomide and prednisolone] and Arm 2 (triangles) [receiving zoledronic acid alone]. Numbers of patients receiving each infusion are also shown, by reference to the scale on the right side.

Back to article page

BMC Clinical Pharmacology

ISSN: 1472-6904